1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Next Generation Sequencing (NGS) Global market - Forecast to 2022

Next Generation Sequencing (NGS) Global market - Forecast to 2022

  • November 2016
  • -
  • IQ4I Research & Consultancy Pvt. Ltd
  • -
  • 375 pages

A decade has gone, since the first human genome has been sequenced and sequencing technology has come a long way from the time of introduction as Next generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced since the first human genome was sequenced, which took a decade time and around $3 billion. But now a human genome can be sequenced at a cost of just $1,000 in one to two days. In the last five years the sequencing cost has rapidly reduced and this is supposed to have a huge impact on the NGS market in the coming years.

The global Next Generation Sequencing market is expected to grow at a double digit CAGR to reach $14,722.5 million by 2022. The NGS market is classified based on products, technology, end users, application and geography. The global NGS products are further divided into instruments, services and workflow products. The NGS technology is segmented into reversible terminator sequencing, ion semiconductor sequencing, sequencing by ligation, single molecule real time sequencing (SMRT), and others.

The NGS application market is segmented in two different ways, one by sequencing process and the other by field of application. The NGS application market by type of sequencing process has been categorized into genomics, epigenomics, transriptomics, and others. By field of application, the market has been divided into diagnostics, drug discovery and development, biomarker discovery, agriculture and animal research, and others. The NGS market by end users is divided into academic research laboratories, hospitals and clinics, biotech and pharmaceuticals, and other end users, which include nonprofit organizations and commercial labs.

Further, the NGS market is separated by geographical regions into North America, Europe, Asia-pacific and Rest of the World.

Table Of Contents

Next Generation Sequencing (NGS) Global market - Forecast to 2022
1 EXECUTIVE SUMMARY 22
2 INTRODUCTION 33
2.1 KEY TAKE AWAYS 33
2.2 REPORT DESCRIPTION 33
2.3 MARKETS COVERED 34
2.4 STAKEHOLDERS 36
2.5 RESEARCH METHODOLOGY 37
2.5.1 MARKET SIZE ESTIMATION 38
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 41
2.5.3 SECONDARY SOURCES 42
2.5.4 PRIMARY SOURCES 42
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 43
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 43
2.5.7 ASSUMPTIONS 44
3 MARKET ANALYSIS 45
3.1 INTRODUCTION 45
3.2 MARKET SEGMENTATION 46
3.3 FACTORS INFLUENCING MARKET 48
3.3.1 DRIVERS AND OPPORTUNITIES 48
3.3.1.1 Reduced cost and high speed 48
3.3.1.2 Increased usage in clinical diagnosis 49
3.3.1.3 Switch to NGS from microarray technology 51
3.3.1.4 New and emerging applications of ngs technology 52
3.3.1.5 Growth of personalized medicine 53
3.3.1.6 Increased medical spending 53
3.3.2 RESTRAINTS AND THREATS 54
3.3.2.1 Complications in NGS data storage 54
3.3.2.2 Standardization of NGS for diagnostic application 55
3.3.2.3 Grants and funding for NGS infrastructure 56
3.3.2.4 Lack of skilled labor 56
3.3.2.5 Huge and complex NGS data interpretation 57
3.3.2.6 Ethical and legal issues to NGS 58
3.4 TECHNOLOGICAL ADVANCEMENTS 59
3.4.1 NANOPORE SEQUENCING BASED TECHNIQUES 59
3.4.1.1 Electronic biosciences nanopore sequencing 59
3.4.1.2 Roche's nanotag chemistry 59
3.4.1.3 Nabsys nanopore sequencer 59
3.4.1.4 Stratos nanopore sequencing 60
3.4.2 ELECTRONIC OPTICA'S MAD-LEEM 60
3.4.3 GENAPSYS GENIUS 60
3.4.4 LASERGEN'S LIGHTENING TERMINATOR CHEMISTRY 60
3.4.5 QUANTUMDX HANDHELD SEQUENCING INSTRUMENT 61
3.4.6 ZS GENETICS ADF-STEM 61
3.5 REGULATORY AFFAIRS 61
3.5.1 U.S. 61
3.5.2 EUROPE 62
3.5.3 CHINA 63
3.5.4 INDIA 64
3.5.5 JAPAN 64
3.6 PORTER'S FIVE FORCE ANALYSIS 65
3.6.1 THREAT OF NEW ENTRANTS 66
3.6.2 THREAT OF SUBSTITUTES 66
3.6.3 BARGAINING POWER OF SUPPLIERS 67
3.6.4 BARGAINING POWER OF BUYERS 67
3.6.5 COMPETITIVE RIVALRY 68
3.7 PATENT TRENDS 68
3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 70
4 NEXT GENERATION SEQUENCING GLOBAL MARKET, BY TECHNOLOGY 72
4.1 INTRODUCTION 72
4.2 REVERSIBLE TERMINATOR SEQUENCING 77
4.3 ION SEMICODUCTOR SEQUENCING 80
4.4 SEQUENCING BY LIGATION 82
4.5 SINGLE MOLECULE REAL-TIME SEQUENCING (SMRT) 85
4.6 OTHERS 87
5 NGS GLOBAL MARKET, BY PRODUCT TYPE 92
5.1 INTRODUCTION 92
5.1.1 INSTRUMENTS 94
5.1.2 SERVICES 98
5.1.2.1 Data analysis services 100
5.1.2.2 Sequencing services 102
5.1.3 WORKFLOW PRODUCTS 104
6 NEXT-GENERATION SEQUENCING GLOBAL MARKET, BY APPLICATION 107
6.1 INTRODUCTION 107
6.2 NGS GLOBAL APPLICATION MARKET, BY PROCESS 107
6.2.1 GENOMICS 109
6.2.1.1 Whole genome sequencing 112
6.2.1.2 Exome sequencing 115
6.2.1.3 Target resequencing 117
6.2.1.4 De novo sequencing 119
6.2.2 EPIGENOMICS 121
6.2.2.1 CHIP sequencing 124
6.2.2.2 Methyl sequencing 126
6.2.3 TRANSCRIPTOMICS 128
6.2.3.1 RNA sequencing 129
6.2.4 OTHERS 131
6.3 NGS GLOBAL APPLICATION MARKET, BY FIELD TYPE 133
6.3.1 DIAGNOSTICS 136
6.3.1.1 Cancer diagnostics 139
6.3.1.2 Infectious disease diagnostics 142
6.3.1.3 Genetic screening 144
6.3.1.4 Transplantation diagnostics 147
6.3.2 DRUG DISCOVERY AND DEVELOPMENT 149
6.3.3 BIOMARKER DISCOVERY 152
6.3.4 AGRICULTURE AND ANIMAL RESEARCH 153
6.3.5 OTHER APPLICATIONS 155
7 NEXT-GENERATION SEQUENCING GLOBAL MARKET, BY END USERS 157
7.1 INTRODUCTION 157
7.2 ACADEMIC RESEARCH 160
7.3 HOSPITALS AND CLINICS 161
7.4 BIOTECH/PHARMACEUTICALS 163
7.5 OTHER END USERS 165
8 NEXT-GENERATION SEQUENCING GLOBAL MARKET, BY REGION 167
8.1 INTRODUCTION 167
8.2 NORTH AMERICA 169
8.2.1 U.S. 180
8.2.2 OTHERS 182
8.3 EUROPE 185
8.3.1 UNITED KINGDOM (U.K.) 196
8.3.2 GERMANY 198
8.3.3 SPAIN 200
8.3.4 OTHERS 202
8.4 ASIA-PACIFIC 204
8.4.1 CHINA 215
8.4.2 SOUTH KOREA 217
8.4.3 AUSTRALIA 219
8.4.4 OTHERS 222
8.5 REST OF THE WORLD 224
8.5.1 BRAZIL 234
8.5.2 SOUTH AFRICA 236
8.5.3 MIDDLE EAST 238
8.5.4 OTHERS 240
9 COMPANY DEVELOPMENTS 243
9.1 INTRODUCTION 243
9.1.1 NEW PRODUCT LAUNCH AS A MAJOR GROWTH STRATEGY OF NGS MARKET PLAYERS 243
9.2 NEW PRODUCT LAUNCH 245
9.3 AGREEMENTS, PARTNERSHIPS and COLLABORATIONS 260
9.4 ACQUISITIONS 272
9.5 OTHER DEVELOPMENTS 275
10 MAJOR PLAYER PROFILES 279
10.1 AGILENT TECHNOLOGIES, INC. 279
10.1.1 OVERVIEW 279
10.1.2 FINANCIALS 280
10.1.3 PRODUCT PORTFOLIO 282
10.1.4 KEY DEVELOPMENTS 285
10.1.5 BUSINESS STRATEGY 288
10.1.6 SWOT ANALYSIS 289
10.2 BGI (BEIJING GENOMICS INSTITUTE) 290
10.2.1 OVERVIEW 290
10.2.2 FINANCIALS 290
10.2.3 PRODUCT PORTFOLIO 291
10.2.4 KEY DEVELOPMENTS 292
10.2.5 BUSINESS STRATEGY 294
10.2.6 SWOT ANALYSIS 295
10.3 DNASTAR, INC. 296
10.3.1 OVERVIEW 296
10.3.2 FINANCIALS 296
10.3.3 PRODUCT PORTFOLIO 296
10.3.4 KEY DEVELOPMENTS 297
10.3.5 BUSINESS STRATEGY 298
10.3.6 SWOT ANALYSIS 299
10.4 EUROFIN GENOMICS 300
10.4.1 OVERVIEW 300
10.4.2 FINANCIALS 301
10.4.3 PRODUCT PORTFOLIO 301
10.4.4 KEY DEVELOPMENTS 302
10.4.5 BUSINESS STRATEGY 303
10.4.6 SWOT ANALYSIS 304
10.5 ILLUMINA, INC. 305
10.5.1 OVERVIEW 305
10.5.2 FINANCIALS 306
10.5.3 PRODUCT PORTFOLIO 308
10.5.4 KEY DEVELOPMENTS 312
10.5.5 BUSINESS STRATEGY 318
10.5.6 SWOT ANALYSIS 319
10.6 OXFORD NANOPORE TECHNOLOGIES LTD 320
10.6.1 OVERVIEW 320
10.6.2 FINANCIALS 320
10.6.3 PRODUCT PORTFOLIO 321
10.6.4 KEY DEVELOPMENTS 321
10.6.5 BUSINESS STRATEGY 322
10.6.6 SWOT ANALYSIS 323
10.7 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 324
10.7.1 OVERVIEW 324
10.7.2 FINANCIALS 325
10.7.3 PRODUCT PORTFOLIO 327
10.7.4 KEY DEVELOPMENTS 331
10.7.5 BUSINESS STRATEGY 335
10.7.6 SWOT ANALYSIS 336
10.8 QIAGEN N.V. 337
10.8.1 OVERVIEW 337
10.8.2 FINANCIALS 338
10.8.3 PRODUCT PORTFOLIO 340
10.8.4 KEY DEVELOPMENTS 343
10.8.5 BUSINESS STRATEGY 348
10.8.6 SWOT ANALYSIS 349
10.9 ROCHE HOLDINGS AG 350
10.9.1 OVERVIEW 350
10.9.2 FINANCIALS 351
10.9.3 PRODUCT PORTFOLIO 354
10.9.4 KEY DEVELOPMENTS 356
10.9.5 BUSINESS STRATEGY 359
10.9.6 SWOT ANALYSIS 360
10.10 THERMO FISHER SCIENTIFIC, INC. 361
10.10.1 OVERVIEW 361
10.10.2 FINANCIALS 362
10.10.3 PRODUCT PORTFOLIO 364
10.10.4 KEY DEVELOPMENTS 368
10.10.5 BUSINESS STRATEGY 373
10.10.6 SWOT ANALYSIS 374"


Companies mentioned

AGILENT TECHNOLOGIES, INC.
BGI (BEIJING GENOMICS INSTITUTE)
DNASTAR, INC.
EUROFIN GENOMICS
ILLUMINA, INC.
OXFORD NANOPORE TECHNOLOGIES LTD
PACIFIC BIOSCIENCES
QIAGEN N.V.
ROCHE HOLDINGS
THERMO FISHER SCIENTIFIC
LIST OF COMPANIES MENTIONED IN REPORT
10X GENOMICS
ADAPTIVE BIOTECHNOLOGIES CORPORATION
AGILENT TECHNOLOGIES
AMOY DIAGNOSTICS CO
ARCHERDX
ASURAGEN
BGI
BIOMATTERS LTD
BIOMERIEUX
CANCER GENETICS, INC.
CAREDX, INC.
DANAHER CORPORATION
DIRECT GENOMICS
DNA ELECTRONICS
DNASTAR, INC.
DNAVISION SA
ELECTRON OPTICA
ELECTRONIC BIOSCIENCES
EUROFINS SCIENTIFIC
FLOWJO LLC
GENAPSYS,INC.
GENEWIZ
GENOMATIX SOFTWARE GMBH
IGENOMIX
ILLUMINA, INC.
INVICTA
MACROGEN
NABSYS
NOBLEGEN
NOVOGENE
OXFORD NANOPORE TECHNOLOGIES
PACIFIC BIOSCIENCES
QIAGEN N.V.
QUANTUMDX
REAL TIME GENOMICS
ROCHE HOLDINGS
SEQOMICS
SERACARE LIFE SCIENCES
STRAND LIFESCIENCES PVT LTD
STRATOS GENOMICS
THERMO FISHER SCIENTIFIC, INC.
TOMA BIOSCIENCES
TWO PORE GUYS, INC.
VELA DIAGNOSTICS
VERITAS GENETICS
WAFERGEN BIOSYSTEMS
ZS GENETICS
"
LIST OF TABLES

TABLE 1 NGS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 27
TABLE 2 NGS GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 28
TABLE 3 NGS GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN) 29
TABLE 4 NGS GLOBAL MARKET REVENUE, BASED ON PROCESS OF APPLICATION, (2014-2022) ($MN) 30
TABLE 5 NGS GLOBAL MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN) 31
TABLE 6 NGS GLOBAL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN) 32
TABLE 7 NGS GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 76
TABLE 8 REVERSIBLE TERMINATOR SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 79
TABLE 9 ION SEMICONDUCTOR SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 81
TABLE 10 SEQUENCING BY LIGATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 84
TABLE 11 SINGLE MOLECULE REAL-TIME SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 86
TABLE 12 OTHERS SEQUENCING TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 91
TABLE 13 NGS GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN) 94
TABLE 14 NGS INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 98
TABLE 15 NGS SERVICES GLOBAL MARKET REVENUE, BY TYPE,
(2014-2022) ($MN) 99
TABLE 16 NGS SERVICES GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 99
TABLE 17 DATA ANALYSIS SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 101
TABLE 18 SEQUENCING SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 103
TABLE 19 WORKFLOW PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 106
TABLE 20 NGS GLOBAL MARKET REVENUE, BASED ON PROCESS OF APPLICATION, (2014-2022) ($MN) 109
TABLE 21 GENOMICS APPLICATION GLOBAL MARKET REVENUE, BY TYPE,
(2014-2022) ($MN) 111
TABLE 22 GENOMICS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 112
TABLE 23 WHOLE GENOME SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 114
TABLE 24 EXOME SEQUENCING GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 117
TABLE 25 TARGETED SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 119
TABLE 26 DE NOVO SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 121
TABLE 27 EPIGENOMICS APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 123
TABLE 28 EPIGENOMICS GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 123
TABLE 29 CHIP SEQUENCING GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 125
TABLE 30 METHYL SEQUENCING GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 128
TABLE 31 RNA SEQUENCING (TRANSCRIPTOMICS) GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 131
TABLE 32 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 133
TABLE 33 NGS GLOBAL MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN) 136
TABLE 34 DIAGNOSTICS APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 138
TABLE 35 DIAGNOSTICS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 139
TABLE 36 CANCER DIAGNOSTICS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 141
TABLE 37 INFECTIOUS DISEASE DIAGNOSTICS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 144
TABLE 38 GENETIC SCREENING APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 146
TABLE 39 TRANSPLANTATION DIAGNOSTICS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 149
TABLE 40 DRUG DISCOVERY AND DEVELOPMENT APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 151
TABLE 41 BIOMARKER DISCOVERY APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 153
TABLE 42 AGRICULTURE AND ANIMAL RESEARCH APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 155
TABLE 43 OTHERS APPLICATION GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 156
TABLE 44 NGS GLOBAL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN) 160
TABLE 45 ACADEMIC RESEARCH GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 161
TABLE 46 HOSPITALS AND CLINICS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 163
TABLE 47 BIOTECH/PHARMACEUTICALS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 164
TABLE 48 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 166
TABLE 49 NGS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 169
TABLE 50 NORTH AMERICAN NGS MARKET REVENUE, BY TECHNOLOGY,
(2014-2022) ($MN) 172
TABLE 51 NORTH AMERICAN NGS MARKET REVENUE, BY COUNTRY,
(2014-2022) ($MN) 173
TABLE 52 NORTH AMERICAN NGS MARKET REVENUE, BY PRODUCTS,
(2014-2022) ($MN) 173
TABLE 53 NORTH AMERICAN NGS SERVICE MARKET REVENUE, BY TYPE,
(2014-2022) ($MN) 174
TABLE 54 NORTH AMERICAN NGS MARKET REVENUE, BASED ON PROCESS OF APPLICATION, (2014-2022) ($MN) 175
TABLE 55 NORTH AMERICAN NGS GENOMICS MARKET REVENUE, BY TYPE,
(2014-2022) ($MN) 176
TABLE 56 NORTH AMERICAN NGS EPIGENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 176
TABLE 57 NORTH AMERICAN NGS APPLICATION MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN) 177
TABLE 58 NORTH AMERICAN NGS DIAGNOSTICS APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 178
TABLE 59 NORTH AMERICAN NGS END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 179
TABLE 60 EUROPEAN NGS MARKET REVENUE, BY TECHNOLOGY,
(2014-2022) ($MN) 188
TABLE 61 EUROPEAN NGS MARKET REVENUE, BY COUNTRY, (2014-2022) ($MN) 189
TABLE 62 EUROPEAN NGS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN) 189
TABLE 63 EUROPEAN NGS SERVICE MARKET REVENUE, BY TYPE,
(2014-2022) ($MN) 190
TABLE 64 EUROPEAN NGS MARKET REVENUE, BASED ON PROCESS OF APPLICATION, (2014-2022) ($MN) 191
TABLE 65 EUROPEAN NGS GENOMICS MARKET REVENUE, BY TYPE,
(2014-2022) ($MN) 192
TABLE 66 EUROPEAN NGS EPIGENOMICS MARKET REVENUE, BY TYPE,
(2014-2022) ($MN) 192
TABLE 67 EUROPEAN NGS MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN) 193
TABLE 68 EUROPEAN NGS DIAGNOSTICS APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 194
TABLE 69 EUROPEAN NGS END-USERS MARKET REVENUE, BY TYPE,
(2014-2022) ($MN) 195
TABLE 70 ASIA-PACIFIC NGS MARKET REVENUE, BY TECHNOLOGY,
(2014-2022) ($MN) 208
TABLE 71 ASIA-PACIFIC NGS MARKET REVENUE, BY COUNTRY,
(2014-2022) ($MN) 209
TABLE 72 ASIA-PACIFIC NGS MARKET REVENUE, BY PRODUCTS,
(2014-2022) ($MN) 210
TABLE 73 ASIA-PACIFIC NGS SERVICE MARKET REVENUE, BY TYPE,
(2014-2022) ($MN) 210
TABLE 74 ASIA-PACIFIC NGS MARKET REVENUE, BASED ON PROCESS OF APPLICATION (2014-2022) ($MN) 211
TABLE 75 ASIA-PACIFIC NGS GENOMICS MARKET REVENUE, BY TYPE,
(2014-2022) ($MN) 212
TABLE 76 ASIA-PACIFIC NGS EPIGENOMICS MARKET REVENUE, BY TYPE,
(2014-2022) ($MN) 212
TABLE 77 ASIA-PACIFIC NGS APPLICATION MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN) 213
TABLE 78 ASIA-PACIFIC NGS DIAGNOSTICS APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 214
TABLE 79 ASIA-PACIFIC NGS MARKET REVENUE, BY END-USERS,
(2014-2022) ($MN) 215
TABLE 80 REST OF THE WORLD NGS MARKET REVENUE, BY TECHNOLOGY,
(2014-2022) ($MN) 227
TABLE 81 REST OF THE WORLD NGS MARKET REVENUE, BY COUNTRY,
(2014-2022) ($MN) 228
TABLE 82 REST OF THE WORLD NGS MARKET REVENUE, BY PRODUCT,
(2014-2022) ($MN) 229
TABLE 83 REST OF THE WORLD NGS SERVICE MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 229
TABLE 84 REST OF THE WORLD NGS MARKET REVENUE, BASED ON PROCESS OF APPLICATION, (2014-2022) ($MN) 230
TABLE 85 REST OF THE WORLD NGS GENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 231
TABLE 86 REST OF THE WORLD NGS EPIGENOMICS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 231
TABLE 87 REST OF THE WORLD NGS APPLICATION MARKET REVENUE, BASED ON FIELD OF APPLICATION, (2014-2022) ($MN) 232
TABLE 88 REST OF THEWORLD NGS DIAGNOSTICS APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 233
TABLE 89 REST OF THE WORLD NGS MARKET REVENUE, BY END-USERS,
(2014-2022) ($MN) 234
TABLE 90 NEW PRODUCT LAUNCH (2014-2016) 245
TABLE 91 AGREEMENTS, PARTNERSHIP and COLLABOARTION (2014-2016) 260
TABLE 92 ACQUISITIONS (2014-2016) 272
TABLE 93 OTHER DEVELOPMENTS (2014-2016) 275
TABLE 94 AGILENT TECHNOLOGIES INC: TOTAL REVENUE AND RandD EXPENSES, (2014-2016) ($MN) 280
TABLE 95 AGILENT TECHNOLOGIES INC.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 281
TABLE 96 AGILENT TECHNOLOGIES INC.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 282
TABLE 97 ILLUMINA INC: TOTAL REVENUE AND RandD EXPENSES
(2014-2016) ($MN) 306
TABLE 98 ILLUMINA INC: TOTAL REVENUE, BY SEGMENTS, (2014 -2016) ($MN) 307
TABLE 99 ILLUMINA INC, : TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 308
TABLE 100 PACIFIC BIOSCIENCES: TOTAL REVENUE AND RandD EXPENSES
(2014-2016) ($MN) 325
TABLE 101 PACIFIC BIOSCIENCES: TOTAL REVENUE, BY SEGMENT,
(2014-2016) ($MN) 326
TABLE 102 PACIFIC BIOSCIENCES: TOTAL REVENUE, BY GEOGRAPHY,
(2014-2016) ($MN) 327
TABLE 103 QIAGEN N.V.: TOTAL REVENUE AND RandD EXPENSES,
(2014-2016) ($MN) 338
TABLE 104 QIAGEN N.V.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 339
TABLE 105 QIAGEN N.V.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 340
TABLE 106 ROCHE HOLDINGS AG: TOTAL REVENUE AND RandD EXPENSES,
(2014-2016) ($MN) 351
TABLE 107 ROCHE HOLDINGS AG: TOTAL REVENUE BY SEGMENTS,
(2014-2016) ($MN) 352
TABLE 108 ROCHE HOLDINGS AG: DIAGNOSTICS REVENUE BY TYPES,
(2014-2016) ($MN) 353
TABLE 109 ROCHE HOLDINGS AG: TOTAL REVENUE, BY GEOGRAPHY,
(2014-2016) ($MN) 354
TABLE 110 THERMOFISHER SCIENTIFIC, INC.: TOTAL REVENUE AND RandD EXPENSES, (2014-2016) ($MN) 362
TABLE 111 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 363
TABLE 112 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 364


LIST OF FIGURES


FIGURE 1 NGS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN) 26
FIGURE 2 NGS GLOBAL MARKET: RESEARCH METHODOLOGY 38
FIGURE 3 NGS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 39
FIGURE 4 NGS GLOBAL MARKET: FORECASTING MODEL 40
FIGURE 5 NGS GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION 41
FIGURE 6 NGS GLOBAL MARKET: MARKET SEGMENTATION 46
FIGURE 7 MARKET DYNAMICS 48
FIGURE 8 NGS GLOBAL MARKET: PORTER'S ANALYSIS 65
FIGURE 9 NGS GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS
(2011-2016) 69
FIGURE 10 NGS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS (2015) (%) 70
FIGURE 11 NGS GLOBAL MARKET SHARE, BY TECHNOLOGY, (2015 V'S 2022) (%) 73
FIGURE 12 NGS PLATFORM INSTALLATION BASE (2015) (%) 74
FIGURE 13 NGS TECHNOLOGY GLOBAL MARKET SCENARIO, (2014-2022)
CAGR (%) 75
FIGURE 14 NGS GLOBAL MARKET SHARE, BY PRODUCTS, (2015 V'S 2022) (%) 93
FIGURE 15 NGS GLOBAL MARKET SHARE, BASED ON PROCESS OF APPLICATION, (2015) (%) 108
FIGURE 16 GENOMICS APPLICATION GLOBAL MARKET REVENUE, BY TYPE,
(2015 V'S 2022) ($MN) 110
FIGURE 17 EPIGENOMICS GLOBAL MARKET REVENUE, BY TYPE,
(2015 V'S 2022) ($MN) 122
FIGURE 18 NGS GLOBAL MARKET SHARE, BASED ON FIELD OF APPLICATION, (2015) (%) 135
FIGURE 19 DIAGNOSTICS APPLICATION GLOBAL MARKET SHARE, BY TYPE,
(2015 V'S 2022) (%) 137
FIGURE 20 NGS GLOBAL MARKET REVENUE, BY END USERS,
(2015 V'S 2022) ($MN) 158
FIGURE 21 NGS END-USERS MARKET SHARE, BASED ON NUMBER OF INSTRUMENTS INSTALLED (2015) (%) 159
FIGURE 22 NGS GLOBAL MARKET REVENUE, BY REGION, (2014 - 2022) ($MN) CAGR (%) 168
FIGURE 23 NORTH AMERICAN NGS GLOBAL MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 170
FIGURE 24 NORTH AMERICAN NGS GLOBAL MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 171
FIGURE 25 U.S. NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 181
FIGURE 26 U.S. NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 182
FIGURE 27 OTHERS NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 183
FIGURE 28 OTHERS NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 184
FIGURE 29 EUROPEAN NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 186
FIGURE 30 EUROPEAN NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 187
FIGURE 31 U.K. NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 197
FIGURE 32 U.K. NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 198
FIGURE 33 GERMANY NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 199
FIGURE 34 GERMANY NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 200
FIGURE 35 SPAIN NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 201
FIGURE 36 SPAIN NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 202
FIGURE 37 OTHERS NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 203
FIGURE 38 OTHERS NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 204
FIGURE 39 ASIA-PACIFIC NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 206
FIGURE 40 ASIA-PACIFIC NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 207
FIGURE 41 CHINA NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 216
FIGURE 42 CHINA NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 217
FIGURE 43 SOUTH KOREA NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 218
FIGURE 44 SOUTH KOREA NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 219
FIGURE 45 AUSTRALIA NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 220
FIGURE 46 AUSTRALIA NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 221
FIGURE 47 OTHERS NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 223
FIGURE 48 OTHERS NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 224
FIGURE 49 REST OF THE WORLD NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 225
FIGURE 50 REST OF THE WORLD NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 226
FIGURE 51 BRAZIL NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 235
FIGURE 52 BRAZIL NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 236
FIGURE 53 SOUTH AFRICA NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 237
FIGURE 54 SOUTH AFRICA NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 238
FIGURE 55 MIDDLE EAST NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 239
FIGURE 56 MIDDLE EAST NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 240
FIGURE 57 OTHERS NGS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS and END-USERS, (2015 V'S 2022) ($MN) 241
FIGURE 58 OTHERS NGS MARKET REVENUE, BASED ON PROCESS and FIELD OF APPLICATION, (2015 V'S 2022) ($MN) 242
FIGURE 59 KEY GROWTH STRATEGIES (2014-2016) 244
FIGURE 60 SWOT: AGILENT TECHNOLOGIES, INC. 289
FIGURE 61 SWOT: BGI (BEIJING GENOMICS INSTITUTE) 295
FIGURE 62 SWOT: DNASTAR, INC. 299
FIGURE 63 SWOT: EUROFIN GENOMICS 304
FIGURE 64 SWOT: ILLUMINA, INC. 319
FIGURE 65 SWOT: OXFORD NANOPORE TECHNOLOGIES LTD 323
FIGURE 66 SWOT: PACIFIC BIOSCIENCES 336
FIGURE 67 SWOT: QIAGEN N.V. 349
FIGURE 68 SWOT: ROCHE HOLDINGS 360
FIGURE 69 SWOT: THERMO FISHER SCIENTIFIC 374

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
The Chinese Market for DNA Sequencing

The Chinese Market for DNA Sequencing

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about recent advances and trends in the Chinese sequencing industry and market. - Analyze the Chinese sequencing market by workflow, including sample preparation products, ...

Biobanking: Technologies and Global Markets

Biobanking: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Analyze the role biobanks play in the development of new drugs for specific disease treatments. - Learn about the prevailing market size for certain biobank services available ...

Polymerase Chain Reaction (PCR) Technologies and Global Markets

Polymerase Chain Reaction (PCR) Technologies and Global Markets

  • $ 6650
  • Industry report
  • August 2016
  • by BCC Research

This BCC Research report explores the current and future PCR product market, which includes instruments, reagents and consumables, and software and services. It also looks at innovations, market drivers ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.